相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs
Divya Prakash Gnanadhas et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Development of europium doped core-shell silica cobalt ferrite functionalized nanoparticles for magnetic resonance imaging
Bhavesh D. Kevadiya et al.
ACTA BIOMATERIALIA (2017)
Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS
Madhavan Nair et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Tracking development assistance for HIV/AIDS: the international response to a global epidemic
Matthew T. Schneider et al.
AIDS (2016)
Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
Adrian S. Ray et al.
ANTIVIRAL RESEARCH (2016)
Paliperidone Palmitate Intramuscular 3-Monthly Formulation: A Review in Schizophrenia
Yvette N. Lamb et al.
DRUGS (2016)
Triple Activity of Lamivudine Releasing Sulfonated Polymers against HIV-1
Maarten Danial et al.
MOLECULAR PHARMACEUTICS (2016)
Development and characterization of a long-acting nanoformulated abacavir prodrug
Dhirender Singh et al.
NANOMEDICINE (2016)
Persistent HIV-1 replication maintains the tissue reservoir during therapy
Ramon Lorenzo-Redondo et al.
NATURE (2016)
International AIDS Society global scientific strategy: towards an HIV cure 2016
Steven G. Deeks et al.
NATURE MEDICINE (2016)
Saquinavir Loaded Acetalated Dextran Microconfetti - a Long Acting Protease Inhibitor Injectable
Michael A. Collier et al.
PHARMACEUTICAL RESEARCH (2016)
The promise and pitfalls of long-acting injectable agents for HIV prevention
Raphael J. Landovitz et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
Alison L. Hill et al.
PLOS PATHOGENS (2016)
Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment
Ian McGowan et al.
LANCET HIV (2016)
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Rafal Kaminski et al.
SCIENTIFIC REPORTS (2016)
Anti-HIV Drug-Combination Nanoparticles Enhance Plasma Drug Exposure Duration as Well as Triple-Drug Combination Levels in Cells Within Lymph Nodes and Blood in Primates
Jennifer P. Freeling et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice
Pavan Puligujja et al.
ANTIVIRAL RESEARCH (2015)
Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations
Pavan Puligujja et al.
BIOMATERIALS (2015)
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials
Donald G. Stein
BRAIN INJURY (2015)
Stealth anti-CD4 conjugated immunoliposomes with dual antiretroviral drugs - Modern Trojan horses to combat HIV
Lakshmi Narashimhan Ramana et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Sustained-release nanoART formulation for the treatment of neuroAIDS
Rahul Dev Jayant et al.
International Journal of Nanomedicine (2015)
Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice
Luisa Fiandra et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
Mariluz Arainga et al.
RETROVIROLOGY (2015)
A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge
Chasity D. Andrews et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Long-acting rilpivirine for HIV prevention
Akil Jackson et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Cabotegravir long-acting for HIV-1 prevention
Chasity D. Andrews et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission
Martina Kovarova et al.
PLOS PATHOGENS (2015)
Simplification of antiretroviral therapy: a necessary step in the public health response to HIV/AIDS in resource-limited settings
Marco Vitoria et al.
ANTIVIRAL THERAPY (2014)
A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis
A. G. A. Jackson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
Benson J. Edagwa et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Emerging strategies to deplete the HIV reservoir
Nancie M. Archin et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes
Benson J. Edagwa et al.
FASEB JOURNAL (2014)
Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults
William Spreen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Mental, Neurological, and Substance Use Disorders in People Living With HIV/AIDS in Low- and Middle-Income Countries
Dixon Chibanda et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
The Pharmacokinetics of Long-Acting Antipsychotic Medications
Stefano Spanarello et al.
CURRENT CLINICAL PHARMACOLOGY (2014)
Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy
Nagsen Gautam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
Eun Ji Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Functionalizing Nanoparticles with Biological Molecules: Developing Chemistries that Facilitate Nanotechnology
Kim E. Sapsford et al.
CHEMICAL REVIEWS (2013)
The New Small-Molecule Mixed-Lineage Kinase 3 Inhibitor URMC-099 Is Neuroprotective and Anti-Inflammatory in Models of Human Immunodeficiency Virus-Associated Neurocognitive Disorders
Daniel F. Marker et al.
JOURNAL OF NEUROSCIENCE (2013)
Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patients
Qing Ma et al.
JOURNAL OF NEUROVIROLOGY (2013)
Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections
Pavan Puligujja et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Long-acting injectable antiretrovirals for HIV treatment and prevention
William R. Spreen et al.
CURRENT OPINION IN HIV AND AIDS (2013)
Overcoming pharmacologic sanctuaries
Theodore J. Cory et al.
CURRENT OPINION IN HIV AND AIDS (2013)
Long-Acting Antipsychotic Medications
Raman Baweja et al.
CURRENT DRUG TARGETS (2012)
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
Michael C. Thigpen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
J. M. Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tuberculosis and HIV Co-Infection
Andrzej Pawlowski et al.
PLOS PATHOGENS (2012)
In Vitro Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
Masanori Kobayashi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Human Immunodeficiency Virus type 1 Endocytic Trafficking Through Macrophage Bridging Conduits Facilitates Spread of Infection
Irena Kadiu et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Activity and Safety of Synthetic Lectins Based on Benzoboroxole-Functionalized Polymers for Inhibition of HIV Entry
Alamelu Mahalingam et al.
MOLECULAR PHARMACEUTICS (2011)
Macrophage endocytic trafficking of antiretroviral nanoparticles
Irena Kadiu et al.
NANOMEDICINE (2011)
Prodrugs-from Serendipity to Rational Design
Kristiina M. Huttunen et al.
PHARMACOLOGICAL REVIEWS (2011)
Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation
Gerben Van 't Klooster et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive, HIV-1-Infected Individuals Commencing cART? A Randomized, Controlled Study
Alan Winston et al.
CLINICAL INFECTIOUS DISEASES (2010)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
Christina M. Marraa et al.
AIDS (2009)
Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment
Lieven Baert et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy
M. S. Palombo et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2009)
Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS
Huanyu Dou et al.
JOURNAL OF IMMUNOLOGY (2009)
NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery
Ari S. Nowacek et al.
NANOMEDICINE (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
The Challenge of Finding a Cure for HIV Infection
Douglas D. Richman et al.
SCIENCE (2009)
Common AIDS-associated opportunistic infections
Elc Ong
CLINICAL MEDICINE (2008)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
Huanyu Dou et al.
BLOOD (2006)
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Yunping Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Preclinical pharmacokinetics: An approach towards safer and efficacious drugs
SS Singh
CURRENT DRUG METABOLISM (2006)
The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids
EM Persson et al.
PHARMACEUTICAL RESEARCH (2005)
Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors
BC Schweinsburg et al.
JOURNAL OF NEUROVIROLOGY (2005)
Nanosuspensions in drug delivery
BE Rabinow
NATURE REVIEWS DRUG DISCOVERY (2004)
New antiviral nucleoside prodrugs await application
C Anastasi et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Lamivuldine/zidovuldine/abacavir - Triple combination tablet
T Ibbotson et al.
DRUGS (2003)
分享论文
